Ginsenoside Rd in Experimental Stroke: Superior Neuroprotective Efficacy with a Wide Therapeutic Window
- 1 July 2011
- journal article
- research article
- Published by Elsevier BV in Neurotherapeutics
- Vol. 8 (3), 515-525
- https://doi.org/10.1007/s13311-011-0051-3
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Update of the Stroke Therapy Academic Industry Roundtable Preclinical RecommendationsStroke, 2009
- Serendipitous findings while researching oxygen free radicalsFree Radical Biology & Medicine, 2009
- Changes in Experimental Stroke Outcome across the Life SpanJournal of Cerebral Blood Flow & Metabolism, 2009
- Neuroprotection for ischemic stroke: Past, present and futureNeuropharmacology, 2008
- Recommendations for Standards Regarding Preclinical Neuroprotective and Restorative Drug DevelopmentStroke, 1999
- 17β-Estradiol Reduces Stroke Injury in Estrogen-Deficient Female AnimalsStroke, 1999
- Neuroprotective FK506 Does Not Alter In Vivo Nitric Oxide Production During Ischemia and Early Reperfusion in RatsStroke, 1999
- Anti–Intercellular Adhesion Molecule–1 Antibody Reduces Ischemic Cell Damage After Transient But Not Permanent Middle Cerebral Artery Occlusion in the Wistar RatStroke, 1995
- Tirilazad reduces cortical infarction after transient but not permanent focal cerebral ischemia in rats.Stroke, 1992
- Effect of MCI-186 on brain edema in rats.Stroke, 1989